Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/03/2003WO2003031590A3 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
07/03/2003WO2003028666A3 Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
07/03/2003WO2003026767A3 Lysin-deficient bacteriophages having reduced immunogenicity
07/03/2003WO2003025187A8 Improvement of gene expression in vectors
07/03/2003WO2003025016A3 Trk polypeptide purification method
07/03/2003WO2003022220A3 Method of generating a transgenic livestock animal
07/03/2003WO2003018788A3 Improved nitroreductase enzymes
07/03/2003WO2003017038A3 A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
07/03/2003WO2003016499A3 Combinatorial methods for inducing cancer cell death
07/03/2003WO2003013437A3 Compositions and methods for the prevention and treatment of huntington's disease
07/03/2003WO2003013229A3 An animal model for parkinson's disease
07/03/2003WO2003013227A9 Yield-related polynucleotides and polypeptides in plants
07/03/2003WO2003010284A3 Antisense modulation of c-reactive protein expression
07/03/2003WO2003008583A3 Novel compositions and methods for cancer
07/03/2003WO2003006623A3 Directed protein modificaiton by iterative sequence insertion
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002100163A3 Cotton event moni5985 and compositions and methods for detection
07/03/2003WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/03/2003WO2002094861A3 Genes and proteins involved in the biosynthesis of enediyne ring structures
07/03/2003WO2002090507A3 Oligonucleotide inhibitors of cancer cell proliferation
07/03/2003WO2002090495A8 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
07/03/2003WO2002090383A3 M. catarrhalis antigens
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002083080A9 Method of treating arthritis using lentiviral vectors in gene therapy
07/03/2003WO2002081691A3 Abcg5 and abcg8: compositions and methods of use
07/03/2003WO2002074942B1 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
07/03/2003WO2002074802A3 Recombinant p. vivax merozoite protein-1 p42 vaccine
07/03/2003WO2002072789A3 Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070672A3 Plant cell having animal-type sugar chain adding function
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002061073A3 Mutwnt fish for genetic screebibg of lipid and cholesterol metabolism
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002057468A3 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
07/03/2003WO2002057305A3 A gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
07/03/2003WO2002050285A3 Histone deacetylase-related gene and protein
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002046408A3 Human proteins, polynucleotides encoding them and methods of using the same
07/03/2003WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins
07/03/2003WO2002040668A3 Proteins and dna sequences underlying these proteins used for treating inflammations
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002031203A9 High throughput or capillary-based screening for a bioactivity or biomolecule
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003WO2002026804A3 84241, a human ring finger family member and uses thereof
07/03/2003WO2002026789A9 Nucleotide sequences mediating male fertility and method of using same
07/03/2003WO2002024888A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2002022801A9 Mammalian receptor genes and uses
07/03/2003WO2002020849A3 Gene markers useful for detecting skin damage in response to ultraviolet radiation
07/03/2003WO2002020049A3 Eiav chimeric vaccine and diagnostic
07/03/2003WO2002012478A3 Methyl-d-erythritol phosphate pathway genes
07/03/2003WO2002012447B1 Isolation and use of solid tumor stem cells
07/03/2003WO2002008289A3 Novel proteins and nucleic acids encoding same
07/03/2003WO2002008281A3 Bstp-cad protein and related reagents and methods of use thereof
07/03/2003WO2002006317A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/03/2003WO2002000940A9 Image analysis for phenotyping sets of mutant cells
07/03/2003WO2002000938A9 Methods and compositions for transcription-based nucleic acid amplification
07/03/2003WO2001083750A9 Dendritic cell co-stimulator molecules
07/03/2003WO2000031303A3 Methods for stool sample preparation
07/03/2003US20030126648 Plasmid coding virginiae butanolide; virginiamycin; BAR receptor binding proteins
07/03/2003US20030126647 Method for inducing seed development by down-regulating expression of the FIS2 gene
07/03/2003US20030126646 Nuclear fertility restorer genes and methods of use in plants
07/03/2003US20030126645 Expression vectors for modifying oil and size phenotypes; genetic mapping variation in crop plants
07/03/2003US20030126644 Protocols for the generation of high yield, super productive transgenic plants disturbed in ran/ran-binding protein mediated cellular process
07/03/2003US20030126643 Manipulation of cellulose and/or beta-1,4-glucan
07/03/2003US20030126642 Using the polycomb proteins fertilization independent endosperm (FIE) and medea (MEA) for controlling activities of non-endosperm tissues such as floral meristem
07/03/2003US20030126641 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants
07/03/2003US20030126640 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
07/03/2003US20030126638 Hap2-like transcription factor for use in adjusting lipid expression, phenotype and biosynthesis in crops such as corn, soybean and wheat; antisense agents; gene expression inhibition; leafy cotyledon-1 activator protein (lec1)
07/03/2003US20030126637 Conferring antiviral, bactericidal and fungicidal infection activity monocotyledonous plants
07/03/2003US20030126636 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use
07/03/2003US20030126635 Identification of seeds or plants using phenotypic markers
07/03/2003US20030126634 Methods and compositions for the increase of yield in plants
07/03/2003US20030126633 Genetically engineered potato which produces increased concentration of glucans/polysaccharides through antisense inhibition of branching enzymes and R1 protein
07/03/2003US20030126631 Preparation of heterologous proteins on oil bodies
07/03/2003US20030126630 Plant sterol reductases and uses thereof
07/03/2003US20030126629 Production of a transgenic avian by cytoplasmic injection
07/03/2003US20030126628 Avian oviduct regulatory sequences for controlling expression of interferon in transgenic cells; bioreactors
07/03/2003US20030126627 Beta amyloid precursor protein linked to muscle specific promoter (creatine kinase) for diagnosis and treatment of age related muscle disorders; screening for compounds which reduce beta amyloid protein proteolytic fragments
07/03/2003US20030126626 Rodent model which cultures human liver cells for regeneration of tissues, providing alternative to liver transplantation; side effect reduction; drug screening
07/03/2003US20030126624 Chimeric DNA-binding proteins
07/03/2003US20030125883 Information processing system using nucleotide sequence-related information
07/03/2003US20030125882 Method and apparatus for providing a bioinformatics database
07/03/2003US20030125718 Multiple beam laser sculpting system and method
07/03/2003US20030125542 Magnetic particles for purifying nucleic acids
07/03/2003US20030125541 Replication competent hepatitus C virus and methods of use
07/03/2003US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome
07/03/2003US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines
07/03/2003US20030125534 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125524 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells
07/03/2003US20030125523 Novel neuropilin/growth factor complexes and uses thereof
07/03/2003US20030125522 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
07/03/2003US20030125520 Novel hemopoietin receptor protein, NR10
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125518 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens
07/03/2003US20030125294 Selective toxin expression in angiogenic endothelial cells
07/03/2003US20030125292 Synergistic stimulating immunoglobulin A (IgA) production by administering a nucleic acid encapsulated with a lipid and at least one antigen
07/03/2003US20030125291 A stabilizer for antisense oligonucleotides, enhancing nuclease stability of enzymatic nucleic acid molecules
1 ... 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 ... 4023